We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $1.88 · 4 analysts
Stored first · Google News · Yahoo Finance (English)
Law firm investigates DocGo officers for possib... - Pluang
Law firm investigates DocGo officers for possib... Pluang
Did DocGo Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PR Newswire
Did DocGo Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire
DocGo extends $26M share repurchase program expiration to Dec. 31, 2026 - TradingView
DocGo extends $26M share repurchase program expiration to Dec. 31, 2026 TradingView
DocGo (NASDAQ: DCGO) extends $26M share repurchase program to year-end 2026 - Stock Titan
DocGo (NASDAQ: DCGO) extends $26M share repurchase program to year-end 2026 Stock Titan
Enterprise value to EBITDA forward of DocGo Inc. – NASDAQ:DCGO - TradingView
Enterprise value to EBITDA forward of DocGo Inc. – NASDAQ:DCGO TradingView
Price to book forward of DocGo Inc. – NASDAQ:DCGO - TradingView
Price to book forward of DocGo Inc. – NASDAQ:DCGO TradingView
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 06. | After market close (AMC) | $-0.15 | — | — | $75.4M | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $-0.09 | — | — | $96.03M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $0.22 | — | — | $495.72M | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $0.17 | — | — | $357.04M | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 03. 25. | Canaccord Genuity | — | Maintain | Hold → Hold | — | Canaccord Genuity: Hold |
| 2026. 03. 17. | Stifel | — | Maintain | Buy → Buy | — | Stifel: Buy |
| 2026. 03. 17. | Cantor Fitzgerald | — | Maintain | Overweight → Overweight | — | Cantor Fitzgerald: Overweight |
| 2026. 03. 17. | Needham | — | Maintain | Buy → Buy | — | Needham: Buy |
| 2025. 11. 12. | Canaccord Genuity | — | Maintain | Hold → Hold | — | Canaccord Genuity: Hold |
| 2025. 08. 22. | Canaccord Genuity | — | Maintain | Hold → Hold | — | Canaccord Genuity: Hold |
As of FY2026Q1 · Source: SEC/DART + price data
No holdings data to show.